Matrix metalloproteinase 2 as a pharmacological target in heart failure

PR Gonçalves, LD Nascimento, RF Gerlach… - Pharmaceuticals, 2022 - mdpi.com
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …

Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension

VA Belo, DA Guimarães, MM Castro - Journal of vascular research, 2016 - karger.com
For vascular remodeling in hypertension, it is essential that vascular smooth muscle cells
(VSMCs) reshape in order to proliferate and migrate. The extracellular matrix (ECM) needs …

MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension

TR Vitorino, AF do Prado, SB de Assis Cau… - Biochemical …, 2023 - Elsevier
Hypertension is one of the leading risk factors for the development of heart failure. Despite
being a multifactorial disease, in recent years, preclinical and clinical studies suggest strong …

Sex-related differences of matrix metalloproteinases (MMPs): new perspectives for these biomarkers in cardiovascular and neurological diseases

A Trentini, MC Manfrinato, M Castellazzi… - Journal of Personalized …, 2022 - mdpi.com
It is now established that sex differences occur in clinical manifestation, disease
progression, and prognosis for both cardiovascular (CVDs) and central nervous system …

Matrix metalloproteinases are involved in cardiovascular diseases

A Azevedo, AF Prado, RC Antonio… - Basic & Clinical …, 2014 - Wiley Online Library
This MiniReview describes the essential biochemical and molecular aspects of matrix
metalloproteinases (MMP s) and briefly discusses how they engage in different diseases …

Circulating matrix metalloproteinases and their inhibitors in hypertension

V Fontana, PS Silva, RF Gerlach, JE Tanus-Santos - Clinica Chimica Acta, 2012 - Elsevier
Growing experimental evidence indicates that matrix metalloproteinases (MMPs) are
implicated in many cardiovascular diseases including hypertension and its chronic …

[HTML][HTML] Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension

MM Castro, JE Tanus-Santos, RF Gerlach - Pharmacological research, 2011 - Elsevier
Hypertension is associated with well known structural and functional alterations in both
resistance and conduit arteries, which may be the result from long-lasting high blood …

Rodent models of heart failure: an updated review

AC Gomes, I Falcao-Pires, AL Pires, C Brás-Silva… - Heart failure …, 2013 - Springer
Heart failure (HF) is one of the major health and economic burdens worldwide, and its
prevalence is continuously increasing. The study of HF requires reliable animal models to …

[HTML][HTML] Mechanisms underlying the effects of caloric restriction on hypertension

AA Al Attar, GI Fahed, MM Hoballah, S Pedersen… - Biochemical …, 2022 - Elsevier
Hypertension is a major risk factor for cardiovascular disease (CVD) as well as a major
contributor to all-cause mortality and disability worldwide. The pathophysiology of …

Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension

MMB de Mello, JM Parente, R Schulz, MM Castro - Vascular pharmacology, 2019 - Elsevier
Hypertension is characterized by maladaptive vascular remodeling and enhanced oxidative
stress in the vascular wall. Peroxynitrite may directly activate latent matrix metalloproteinase …